Clinical trial
Neuromodulation for Dysphoria
NCT05061745 is registered in ClinicalTrials.gov with Florida State University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Neuromodulation for Dysphoria
- Lead sponsor
- Florida State University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 29, 2021
- Completion date
- November 14, 2025
- Enrollment
- 29 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
dysphoria